Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NeoCura Logo
NeoCura Growth Score
30
CB Rank
81348
Heat Score
58
NeoCura provides an AI medical platform to improve the precision diagnosis and treatment of tumors.
Founded
obfuscation
PrivateSeries A Beijing, Beijing, China51-100 www.neocura.net
Artificial Intelligence (AI)
Biotechnology
Health Care
Software
Overview

NeoCura
Total Funding
obfuscation
Growth Score
30
Heat Score
58

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score30
0 pts
in past quarter
Heat Score 58
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NeoCura

CB Rank
81348
NeoCura provides an AI medical platform to improve the precision diagnosis and treatment of tumors.
Founded
obfuscation
PrivateSeries A Beijing, Beijing, China51-100 www.neocura.net
Artificial Intelligence (AI)
Biotechnology
Health Care
Software

Funding Rounds

Series A
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Shenzhen Xinhe Bio-Medical Technology Co .Ltd.
Also Known As Shenzhen Xinhe Biomedical
Operating Status Active
Company Type For Profit
About the Company
NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.
Phone Number 010-80766127
Contact Email info@neocura.net
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Drug Screening & Validation Platform
A platform that identifies effective neoantigen combinations for neoantigen therapy and assesses clinical efficacy at molecular and cellular levels.
AI Bioinformatic Target Mining Platform
An AI-driven platform for mining drug targets using bioinformatics and multi-omics big data.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A
obfuscation
Series A - NeoCura Logo
Series A - NeoCura
5
obfuscation
James Yahui, PICC Capital Investment ManagementSeries A

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Contacts 1
News
Technology
View Tech Report

Monthly Web Visits

73
-43.85%
 in past month

Active Website Tech Count

3NeoCura is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Common Name Invalid.
Sub-Organizations
Frequently Asked Questions

Where is NeoCura's headquarters? NeoCura is located in Beijing, Beijing, China.Who invested in NeoCura? NeoCura has 8 investors including PICC Capital Investment Management and  Shunxi Fund.When was the last funding round for NeoCura? NeoCura closed its last funding round on
obfuscation
from a Series A round.Who are NeoCura's competitors? Alternatives and possible competitors to NeoCura may include Tempus, SOPHiA GENETICS, and  Caris Life Sciences.How much funding has NeoCura raised to date? NeoCura has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|